Amgen’s Neupogen® is prescribed to reduce the incidence of infection in cancer patients with nonmyeloid malignancies. The drug is a recombinant (genetically engineered) protein that stimulates the production of infection-fighting white blood cells, called neutrophils, which are depleted by cytotoxic chemotherapy.

Challenge:
Amgen enlisted UX to assist with Neupogen.com, a resource for both patients and doctors. First, Amgen wanted to inform patients how Neupogen would affect their body, as it worked to assist them during their fight against cancer. They needed to understand the process of chemotherapy and where they were within it. It was important for doctors to also know how Neupogen would affect their patients’ bodies and react with other drugs.

Solution:
For patients, UX helped the client assemble a storybook-style online experience to promote ease of use and accessibility of content. For doctors, who have little time for finding needed information, a matrix- approach IA was implemented, and the subjects and nomenclature were clear in both the navigation and on the page.